Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
John C Eppensteiner
Assistant Professor of Emergency Medicine
Emergency Medicine
john.eppensteiner@duke.edu
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
Training & Certifications
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
expertise {hide_children: true, active: false, enabled: true}
Expertise
Keywords
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
Elucidating and mitigating the effects of Damage Associated Molecular Patterns (DAMPs) released following severe traumatic injury.
Research
Co Investigator ·
Awarded by Department of Defense ·
2024 - 2026
Surgical Critical Care Initiative (SC2I): Civilian application of military decision support tools for critically injured patients.
Research
Co Investigator ·
Awarded by Henry M. Jackson Foundation ·
2021 - 2026
A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19
Clinical Trial
Principal Investigator ·
Awarded by Regeneron Pharmaceuticals, Inc. ·
2020 - 2026
A PHASE 2 STUDY TO ASSESS THE VIROLOGIC EFFICACY OF REGN10933+REGN10987 ACROSS DIFFERENT DOSE REGIMENS IN OUTPATIENTS WITH SARS-CoV-2 INFECTION
Clinical Trial
Principal Investigator ·
Awarded by Regeneron Pharmaceuticals, Inc. ·
2020 - 2023
Sc2i
Research
Co Investigator ·
Awarded by Henry M. Jackson Foundation ·
2020 - 2021
Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease
Clinical Trial
Principal Investigator ·
Awarded by Vanderbilt University Medical Center ·
2020 - 2020
SC2i
Research
Fellow ·
Awarded by Henry M. Jackson Foundation ·
2014 - 2020
